ARCHIVES

Increased Lung Cancer Risk After Hodgkin’s Treatment

This article is from The Cancer Letter archive.

Vol. 25 No. 2 | February 22, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Commissioner Holds Up IND While Reviewing Toxicology Guidelines

August 14, 1981

ODAC Member Critical Of Amgen For Price Incentives.

March 21, 2008

Broder: Downward Negotiations Or Coercion? NCI Authorities

June 15, 1990

NSABP’s B-14 Study Reports Deaths From Uterine Cancer Related To Tamoxifen

February 25, 1994

In Brief: Jensen, Selikoff Receive ACS National Awards; CCIRC Schedules Mini-Symposium

October 22, 1976

Univ. Of Pittsburgh Seeks Senior Prevention Trial Of Tamoxifin should Resume

June 17, 1994